Menu Back toSession-2-Track-1-All-Aboard-the-Globalization-Train

Medical Affairs and Scientific Communications Forum

3 Meetings, 1 Location: Medical Communications, Medical Science Liaisons, Medical Writing

Session 2 Track 1: All Aboard the Globalization Train

Session Chair(s)

Taleen  Kalebjian, PharmD

Taleen Kalebjian, PharmD

  • Senior Manager, Medical Information
  • Gilead Sciences, Inc., United States
The trend towards medical information globalization is clear, but the path and final product can look different for each organization. The results from a survey of several biopharmaceutical companies show us why companies decide to globalize, how they approach this process, and key components to a successful shift towards a global medical information department. We will then see some of these key learnings in action as one company shares their globalization journey.
Learning Objective :
  • Describe current trends in medical information globalization in areas including infrastructure, aspects of department globalization, and the use of technology
  • Compare various models of globalization
  • Discuss the value of globalization in regards to the company, the department, and the patient
  • Recognize key challenges associated with globalization and best practices for overcoming them


Mary K. Sendi, PharmD

PhactMI Benchmark Study Results

Mary K. Sendi, PharmD

  • MI Regional Lead North America
  • Pfizer Inc, United States
Ghiesla  Nel

MI Globalization – Partnering with Affiliates

Ghiesla Nel

  • Head of Global Medical Information
  • IPSEN PHARMA, France